Madeline Colli

Senate Bill 47, legalizing medical cannabis, was signed into law in March 2023 by Kentucky Governor Andy Beshear (D).

A new bill is aiming to allow Pennsylvania liquor stores to sell recreational cannabis.

The NBA is giving players the option to invest in the cannabis industry under a new deal.

Our 2023 Portland show features interactive off-site event at ChemHistory, Oregon’s premier compliance laboratory, in an immersive full day experience prior to conference.

Saint Louis University’s (St. Louis, Missouri), Cannabis Science and Operations program received the 2023 Outstanding Program by the University Professional and Continuing Education Association (UPCEA).

In March 2023, Texas lawmakers approved of House Bill 1085.

Physician and cannabis expert, Dr. Peter Grinspoon, has released his new book titled,”Seeing through the Smoke.” In this informative piece of literature, Dr. Grinspoon discusses separating fact from fiction, cannabis research, and a guide on how to use cannabis safely.

Cannabis Patient Care published a wide variety of content throughout 2022—here is just a small snippet of some of the top articles and columns that our readers enjoyed. Click through and see if any of your favorites made the list!

California Senate Public Safety Committee approves of SB-58, legalizing the possession and use of specific psychedelics.

It’s that time of year again—the Cannabis Science and Technology (CST) top 10 articles from the previous year. CST published a wide variety of content throughout 2022—including a lot of video interviews from the Cannabis Science Conference series. Here is just a small snippet of some of the top articles, columns, videos, and podcasts that our readers enjoyed. Click through and see if any of your favorites made the list!

Leaf 411 and Mission Dispensaries look to advance cannabis education through their recent membership.

When you think of cannabis, you probably don’t think of horses or the potential medicinal benefit to animals. However, the cannabinoids found in cannabis have been shown to provide similar benefits in animals that are noted with human patients. In this interview, Emma Davis, founder of Mikko’s Choice, delves into how some cannabinoids—such as tetrahydrocannabinol (THC), cannabidiol (CBD), cannabinol (CBN), and tetrahydrocannabinolic acid (THCA)—have provided medicinal benefits to horses. Davis also discusses her mustang, Mikko, who inspired her to launch her own cannabis and hemp product brand.

Don't miss this Noid Factoid from Dr. Reggie Gaudino, VP of R&D at Front Range Biosciences.

For more than 20 years, Americans for Safe Access (ASA), the largest national member-based organization of patients, medical professionals, scientists, and citizens, have been advocating for cannabis to be seen as a form of medicine. Here, Steph Sherer and Debbie Churgai of ASA discuss the importance of medical cannabis and how advocacy will light the way forward.

When she was three-and-a-half years old, Brooklyn Hall was diagnosed with anaplastic ependymoma, class 3, a rare and unique form of brain cancer. Here, her mother Meghan Hall shares how Brooklyn’s prognosis drastically changed with the help of Rick Simpson Oil.

In a recent announcement, Major League Baseball announced a sponsorship deal with cannabidiol (CBD) company Charlotte’s Web.

Dr. Anthony Macherone of Agilent Technologies shares what he learned at Cannabis Science Conference East 2022.

Dr. Anthony Macherone of Agilent Technologies discusses what he hopes to see change in the future regarding cannabis regulations and testing guidelines.

Dr. Stephen Barnhill, founder, chairman, and CEO of Apollon Formularies, plc., explained to Cannabis Science Conference East 2022 attendees, his findings on how cannabis and mushrooms can be the ultimate weapon in the war against cancer.

Dr. Anthony Macherone of Agilent Technologies discusses some of the unique challenges when developing testing methods for cannabis products.

Dr. Anthony Macherone of Agilent Technologies shares some insights from his talk at Cannabis Science Conference East 2022.

A recent study disclosed how younger generations are experimenting with cannabis and hallucinogenic use at the highest levels according to data from previous years.

When a patient isn’t able to access the care or medication that they need in their home country, they aren’t left with much of a choice but to travel to a country that will give them the treatment they need. In part II of this interview series, Nikki Lawley, founder of Nikki and the Plant, LLC, and retired licensed practical nurse (LPN), continues discussing her journey to health, the broken healthcare system hurting medical cannabis patients in the US, and what needs to change to make access better for patients.

In early June 2022, the New York State Senate approved a bill which mandated public health insurance programs to cover medical cannabis expenses and defined how private insurers are allowed to handle these expenses as well (1).

What happens when traditional medicine fails a patient? When all recourses have been tried and the patient still suffers? In part I of this interview series, Nikki Lawley, founder of Nikki and the Plant, LLC, and retired licensed practical nurse (LPN), takes us through her journey from a medical professional in the healthcare industry to a brain injury survivor. Lawley also describes the medical cannabis industry from a patient perspective, learning about the medicinal properties of the plant, and finding what ways cannabis could be beneficial to her symptoms.

Otha Smith III shares his personal journey with medical cannabis and how it led to founding the Tetragram app.

When it comes to cannabis cultivation, growers have their own methods on how to get the best products from their plants. Through using different soils, irrigation practices, lighting, and other approaches, each item plays an important role in how the plant matures. In this interview, David Cohen, CEO of Fluence, discusses the rise in LED lighting methods and how it can be the best tool for the industry.

Nurse Practitioner Me Fuimaono-Poe discusses how becoming an advocate and assisting with legislation are the best tools to help your state, community, and yourself gain access to cannabis and help others.

Dr. Woody, chief executive officer of 180 Life Sciences, discusses in this interview the current research surrounding synthetic cannabinoids as a treatment for chronic pain, as well as the development of a new type of medication that would have the potential to offer the benefits of cannabis without any undesirable effects.

The science of cannabis is in its beginning stages and has a large opportunity for growth advancement. Market Manager for Cannabis for Shimadzu, Eberhardt Kuhn, Ph.D., will be presenting two talks for both the hemp and analytical tracks, “Starting with the Roots - the Many Uses of Hemp” and “Delta Dawn - the Next Generation of Cannabinoids?” If you are interested in exploring hemp or cannabidiol (CBD) and other cannabinoids, check out both of these presentations to learn more! In this interview, Kuhn also discusses his interests in the cannabis industry and other presenters at the Cannabis Science Conference (CSC) West taking place in Long Beach, California from May 18–20, 2022.